2017_4q_omron_e
36/57 - Management Targets
【テロップ】
※各テロップ文字をクリックすると該当の場所がピンポイントで閲覧できます。
00:37:16.4
In order to execute on the strategies I have discussed so far, we will be proactively investing during the four years covered by VG 2.0 in FA, Healthcare and our core technologies. Please turn to slide 34 for specific targets. We target growth investments, primarily in the form of M&A, to be between ￥100-200 billion. We project R&D spend to be ￥270 billion yen and capex to be ￥160 billion. We believe that proactively investing on a larger scale than under the Earth-1 Stage will allow us to develop a robust growth structure that will serve us well in preparation for where we aim to be in FY2030. Next slide please.
【ノート】
